Third Party Laboratories definition

Third Party Laboratories means any Third Party utilized by Xxxxxxxxxx, with Dyax' prior written approval, subcontracted to perform Services.
Third Party Laboratories means any Third Party utilized by Xxxxxxxxxx, with Dyax' prior written approval, subcontracted to perform Services. 1.47 "Third Party" means any Party other than Dyax, Xxxxxxxxxx and their respective Affiliates. 1.48 "Work Order" means any such appendix to this Agreement specifying Services. Work Order(s) shall be attached to this Agreement and when approved in writing by both Parties, shall be deemed an integral part hereof. Work Order(s) may be updated and/or amended from time to time by mutual written agreement of the Parties. 1.49 "Working Cell Bank" or "WCB" means the clonal cell line that has been designed and engineered to produce DX-2930, and shall be supplied to Xxxxxxxxxx by Dyax. 2. Scope of Services; Management; Work Orders; Performance 2.1

Examples of Third Party Laboratories in a sentence

  • Igenomix reserves the right to carry out part or all of the analyses included in the test through Third Party Laboratories certified with recognised international quality standards, or failing this, they will be periodically assessed by Igenomix.

  • The CA developed a specific document, "Policy on the Use of Third Party Laboratories for Testing Fish and Fish Products under the Fish Inspection Program", establishing in detail the conditions and obligations of private laboratories in order to be able to be used by the CA in their Fish Inspection Program.

  • Bidder may establish a field test Laboratory to execute Civil Construction testing requirements at site with the condition that all testing equipment shall be calibrated from POWERGRID approved accredited Testing laboratories, with calibration certificates kept available at sit e and all testing personnel employed in the Field Testing Laboratories to be qualified and experienced Engineers or testing to be carried out at POWERGRID approved Third Party Laboratories.

  • Based on a Reasonable Testing Program: For non-children's products, the GCC must be based on a test of the product, or a reasonable testing program.o Vendor must use accredited third party laboratories for Children's Products: The vendor must certify the safety of its children's products by sending such products to Accredited Third Party Laboratories for testing, as required by the CPSIA.

  • The vendor must certify the safety of its children's products by sending such products to Accredited Third Party Laboratories for testing, as required by the CPSIA.

  • Igenomix reserves the right to perform part or all the analyses that make up the test through Third Party Laboratories accredited to recognised international quality standards, or otherwise periodically evaluated by Igenomix.

  • Compliance for use in LNG tanks and special structures has been completely assessed by Third Party Laboratories.

  • Contractor may establish a field test Laboratory to execute Civil Construction testing requirements at site with the condition that all testing equipment shall be calibrated from POWERGRID approved accredited Testing laboratories, with calibration certificates kept available at site and all testing personnel employed in the Field Testing Laboratories to be qualified and experienced Engineers or testing to be carried out at POWERGRID approved Third Party Laboratories.

  • Based on a Reasonable Testing Program:For non-children's products, the GCC must be based on a test of the product, or a reasonable testing program.Vendor must use accredited third party laboratories for Children's Products:The vendor must certify the safety of its children's products by sending such products to Accredited Third Party Laboratories for testing, as required by the CPSIA.

  • A letter from the Assistant General Counsel for Regulatory Affairs, Office of the General Counsel, Consumer Product Safety Commission, transmitting the Commission’s final rule — CPSC Acceptance of Third Party Laboratories: Revision to the Notice of Re- quirements for Prohibitions of Children’s Toys and Child Care Articles Containing Specified Phthalates [Docket No.: CPSC- 2017-0043] received February 23, 2108, pursu- ant to 5 U.S.C. 801(a)(1)(A); Public Law 104- 121, Sec.

Related to Third Party Laboratories

  • Participating Clinical Laboratory means a Clinical Laboratory which has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • Non-Participating Clinical Laboratory means a Clinical Laboratory which does not have a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan provide services to you at the time services are rendered.

  • Dental laboratory means a person, firm or corporation

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Therapeutic school means a residential group living facility:

  • Third Party Licensor means the relevant licensor of any Third Party Data or any Third Party Trade Xxxx;

  • Elan means Elan Corp and its Affiliates.

  • Third Party Data has the meaning set forth in Section 9.3(a).

  • Bioassay means the determination of kinds, quantities or concentrations and, in some cases, the locations of radioactive material in the human body, whether by direct measurement, in vivo counting, or by analysis and evaluation of materials excreted or removed from the human body. For purposes of these rules, “radiobioassay” is an equivalent term.

  • Third Party Products means the Third Party Software and Third Party Hardware.

  • Third Party Manufacturer means (i) a Third Party whose primary business is contract manufacturing, or (ii) a Third Party who has a contractual arrangement with Licensee or with a sublicensee of Licensee that includes manufacturing of Client Product and/or Drug Product by such Third Party for Licensee or such sublicensee.

  • BMS means the Company, all related companies, affiliates, subsidiaries, parents, successors, assigns and all organizations acquired by the foregoing.

  • IMS has the meaning set forth in Section 6.5.4(i).

  • Testing laboratory means a laboratory, facility, or entity in the state that offers or performs tests of cannabis or cannabis products and that is both of the following:

  • Third Party Vendor means any person or entity that provides SaaS, third party software and/or related intellectual property. “Work” means any additional work the Customer requests Singtel to perform in relation to the Service.

  • Collaborative law communication means a statement, whether oral or in a record, or verbal or nonverbal, to which both of the following apply:

  • DS Electric generation service that is provided at retail pursuant to the Applicable Legal Authorities under the Company’s retail electric tariffs and under any other agreements or arrangements between the Company and Customers, to any Customer that is not being served by an EGS. Default Allocation Assessment – shall have the meaning ascribed to it under the PJM Agreements. Delivery Period – The delivery period specified in an Appendix C Transaction Confirmation. Delivery Point – Means the applicable zone of the Company as designated by PJM. DS Customer(s) – Retail customers who are provided Default Service pursuant to the terms of this Agreement, the Applicable Legal Authorities and the Company’s retail tariffs.

  • Radiopharmaceutical quality assurance means, but is not limited to, the performance of appropriate chemical, biological, and physical tests on potential radiopharmaceuticals and the interpretation of the resulting data to determine their suitability for use in humans and animals, including internal test assessment, authentication of product history, and the keeping of proper records.

  • Novartis shall have the meaning set forth in the Preamble.

  • Third Party Technology means all Intellectual Property and products owned by third parties and licensed pursuant to Third Party Licenses.

  • Third Party License means licenses from third parties governing third party software embedded or used in the Trading Platform.

  • Merck has the meaning set forth in the preamble.

  • HITECH means the Health Information Technology for Economic and Clinical Health Act.

  • Collaboration Technology means all Collaboration Patents and Collaboration Know-How.

  • ISIS means the department’s individualized services information system.